by guest on November 7, 2016 http://toxsci.oxfordjournals.org/ Downloaded from 2 ABSTRACT Meta-and re-analyses of the available data for the neurobehavioral effects of acute inhalation exposure to toluene were reported by Benignus et al. (2007) . The present study was designed to test the generality of the toluene results in as many other solvents as possible by further meta-and re-analyses. Sufficient data for meta-analyses were found for only four solvents; toluene, trichloroethylene, perchloroethylene and 1,1,1trichloroethane. The results for these solvents showed that rats were less affected by each of the solvents when they were tested in highly-motivating situations, e.g., rewarded for rapid or correct responding or escape from electrical shock, compared to less motivating circumstance. The four solvents did not differ significantly in potency on any outcome measure when dose was expressed as molar brain concentration. When tested in tasks with low motivational contingencies, the dose-effect curves of humans (reaction times) and rats (electrophysiological responses to visual stimuli) were not significantly different.
INTRODUCTION
Acute inhalation exposures to volatile organic compounds at high concentrations produce sedation, immobility, anesthesia and unconsciousness. At lower concentrations, exposure to these substances impairs neurological function and degrades performance of behavioral tasks. One important goal of toxicological research is to predict the magnitude of such impairments in humans as a function of exposure so that, e.g., benefit/cost relationships of different pollution-control options can be estimated . To this end, it has been shown that, in rats, the magnitude of decrease in the amplitude of visual evoked potentials (VEP) and accuracy of signal detection (SIGDET) and increase in reaction time (RT) of SIGDET were related to momentary brain concentrations of toluene (TOL), trichloroethylene (TCE) or perchloroethylene (PERC) (Benignus et al.1998; Boyes et al., 2005 Boyes et al., , 2007 Boyes et al., , 2009 Bushnell et al., 1997 Bushnell et al., , 2007 . The same was previously demonstrated for human RT with TOL (Benignus et al., 1998 . To make such predictive functions more generally applicable, it is also necessary to consider additional factors, including the compounds of concern and the nature of the behavioral or neurological assessment tests. Benignus et al. (2007) reported results of meta-and re-analyses of the available data for the neurobehavioral effects of acute inhalation exposure to TOL. To provide a common independent variable for all studies, physiologically-based pharmacokinetic (PBPK) models were used to estimate molar concentrations of TOL in the brain from the concentration of the solvent in the inhaled air and the duration of exposure. Dependent variables from each study were also transformed to a common measurement scale of effect magnitude (E) which ranged from 0.0 to 1.0 with E = 0.0 signifying "no effect" and 4 E = 1.0 the maximum possible effect. Thus, the use of common scales for brain solvent concentration and E permitted pooling of data that were originally measured in diverse manners. Pooling the transformed data made it possible to fit logistic equations (Benignus, 2001; Corso, 1967) to estimate dose-effect functions in the combined experimental data.
Interpretation of these findings depended upon a well-defined concept of motivation. Implicitly in the earlier work and explicitly in the present article, we defined "motivation" as an independent variable the application of which influences the probability, speed, strength or accuracy of a response (Nevin, 1974) . A ready example of such an independent variable is pay for work. Here we contend that such an applied motivator can be ranked for strength, e.g., escape from or avoidance of electrical shock (ES-AV) exerts a stronger control over behavior than food presentation. We have chosen to assign the rank of "minimum" to any case in which there no explicit motivator was applied to control neurobehavioral responses. The above ranking is consistent with examples given in the work of Nevin (1974) .
The results of the TOL meta-and re-analyses ) were interpreted to mean (a) that the magnitude of the neurobehavioral effects of TOL depended upon the strength of the motivation applied in the behavioral tasks (b) that rats and humans were approximately equally sensitive to TOL exposure when both were tested under minimum motivation (c) that if humans were performing under more highly motivated conditions, their dose-effect curves would be equivalent to those of similarlymotivated rats and (d) that human performance under conditions of low motivation could be predicted from rat data collected under stronger motivational control by use of dose-equivalence equations (DEEs) (Benignus, 2001) . The DEE permits an empirical, quantitative approach to rat-to-human extrapolation of neurobehavioral effects regardless of differences in testing situations.
A direct test of the hypothesis in (c) above, that the behaviors of rats and humans would be equally sensitive to TOL if the strength of the applied motivation were equal, would require data collected under different motivation strengths in both species. Such data exist for rats, but not for humans. Behavioral tasks used in controlled laboratory tests of human volunteers traditionally involved minimal motivation. Specifically, subjects were paid a fixed amount to participate but not explicitly rewarded for correct or rapid responses. They were simply instructed to do well. Thus their performance depended only on imputed internal motivation to comply with the experimental instructions and the accuracy and speed of their responses were not influenced by explicit contingencies applied by the experimenter.
The purpose of the present study was to perform meta-and re-analyses to quantify the behavioral and/or neurological impairments of acute inhalation exposure for all solvents for which results had been reported with sufficient information in the extant literature. After extensive searches it was determined that sufficient data existed for four solvents: TOL, TCE, PERC and 1,1,1-trichloroethane (TCA). The following hypotheses were proposed: H 1 : Regardless of the solvent tested, the magnitude of the neurobehavioral effect (E) is a direct function of the concentration of that solvent in the brain and an inverse function of the motivation that was applied to control the performance of the task Page 5 of 39  Toxicological Sciences   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 H 2 : The individual solvents have different potencies for affecting E, when dose was expressed as in molar solvent concentration in the brain.
H 3 : Dose-effect curves based on molar solvent concentration in the brain do not differ significantly between rats and humans when motivational conditions are similar.
METHOD

DEFINITION OF MOTIVATION
The applied motivational rankings were defined as "minimum", "medium" or "high" as specified in Table 1 for the specific neurobehavioral measurements which were encountered in the present work. Clearly, conditions other than those given in Table 1 are typically considered to influence the strength of motivation, e.g., the magnitude of reward or punishment or the "self motivation" to do well. Nevertheless, even when the motivational ranks were implicitly defined using only information as in Table 1 , the motivation variable accounted for a major amount of variance in determining the effects of TOL .
LITERATURE REVIEWS (META-ANALYSES)
Peer-reviewed reports of neurobehavioral effects of acute inhalation exposure to solvents were collected via extensive literature searches without limits on publication dates. Each report was screened to assure that it could be meta-analyzed by the method of Benignus (2001) . The minimum requirements for acceptable reports included (a)
interval-or ratio-scaled (Stevens, 1951) dependent variables (b) a baseline (non-exposed) value for the dependent variables (c) numerical values of inhaled-air concentration of the solvent (d) a specified duration of exposure before neurobehavioral testing and (e) the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 7 duration of the neurobehavioral tests. In some cases sufficient methodological detail was available to permit deduction of the specific quantities when they were not given explicitly. Unlike previous reports, the present effort also required reporting of some measure of variance around means so that confidence limits could be more accurately estimated (see below).
The general aim was to collect data involving central nervous system function.
For both rats and humans, when several dependent variables were measured in one experiment, a preference was given to RT rather than other less common variables. Some dependent variables were excluded. For example, unconditioned motor activity data were not used because they typically exhibit an inverted-U-shaped dose-effect curve, different from other behavioral tasks.
Both statistically-significant and non-significant data were included on the grounds that all data should enter into the curve fitting even if effects did not exceed typical criteria for statistical significance. Lack of significant effects could have been due to a small number of subjects or large variance in a single study. In either case, the means represent the best available estimate of the effects of that exposure. In a pool of data larger than the original study, the non-significant data still enter into a fitting procedure and help determine the shape of the curves.
RE-ANALYSES OF RAW DATA
Raw data from rats were available for TOL Bushnell et al. 2007 ), TCE Bushnell et al., 1997) and PERC (Boyes et al., 2009; Oshiro et al. 2008) . These data were re-analyzed to fit dose-effect functions using the same methods as for TOL . were used as published except for those relating to body size or activity level; these were set to reflect the conditions of the experiment being simulated.
The TOL model for humans was given in Benignus et al. (2006) and for rats in Kenyon et al. (2008) . The TCA rat model was taken from Lu et al. (2008) and for humans from Droz et al. (1989) . The PERC rat and human models were taken from Thrall et al. (2002) in which the human brain/blood partition coefficient was calculated by dividing the rat brain/air coefficient by the human blood/air coefficient. The TCE model for rats was taken from Simmons et al. (2002) and human model from Dobrev et al. (2002) A program was written in ACSL Xtreme (AEGis Technologies Group, Inc., Huntsville, AL) to simulate the exposure scenarios in each experiment used in the present were included to estimate as accurately as possible the concentration of the solvent in the brain at the time of testing. The mean concentration of the solvent in the brain during the testing period was then used as the measure of dose to generate dose-effect functions for each measure of effect. Physiological values appropriate for the rats being tested (Kenyon et al., 2008; Simmons et al., 2002) were applied in the present work. Physical values for humans were estimated (when authors did not report them) from a human whole-body physiological model (QCP) (The Modeling Workshop, The University of Mississippi Medical School, http//physiology.umc.edu) which had been independently verified against published data (Benignus et al., 2006) .
QUANTIFICATION AND TRANSFORMATION OF DEPENDENT VARIABLES
When dependent variable values were given numerically, the data were entered into a data base and then checked against original data. When data were graphically presented, the graphs were scanned and digitized (UnScanIt, www.silkscientific.com).
Each dependent variable was then transformed into the E scale. The transform was defined by the E scale's desired properties and the properties of the original (reported) measurement scale . Thus each transform is unique to the properties of the original scale. When the original scale descended as the effect of treatment increased, the computations transformed the dependent variable into a proportion of the baseline (control). When the original scale ascended as the effect increased, it was first inverted to avoid division by baseline values that may approach zero. The process is described in Benignus et al. (2007) .
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STATISTICS
Dose-effect curves were fitted using the logistic equation with PROC NLMIXED (SAS, Cary, NC). Confidence limits for the fitted dose-effect equations were computed by NLMIXED, directly from the data if raw data were being fitted. If a large number of means were fitted instead of raw data, the confidence limits computed by NLMIXED were still good approximations to those computed for the raw data . When a publication reported only a few means and some measure of variance, a simulated raw data set was constructed using Monte-Carlo methods. The simulated data had the same number of subjects as in the original data and was constructed by generating random numbers with the correct mean and standard deviation (SD) for each of the means reported. Exact equality of SD between the original and simulated data was achieved by adjusting the simulated data (by multiplying all simulated data by the ratio of the SDs of original and simulated data). Similarly, the means of the simulated data were adjusted by adding the difference between the two means. After adjustment, the simulated data set had statistical properties identical to those of the original reported data set. The simulated data were then used to fit the dose-effect functions. The Monte-Carlo 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 method was tested by computing means and SDs of a raw data set and comparing curve fits. This comparison yielded equivalent results for the two data sets. It should be noted that this method cannot account for possible correlations among repeated measures unless the correlations or covariances are reported, which was not done in any of the publications. To the extent that such correlations exist, the present method errs by overestimating the width of the confidence intervals.
The logistic equation used for the dose-effect curves is
in which E is the effect magnitude, exp is the natural antilog, ln is the natural log and D is the estimated concentration of the solvent in the brain. After fitting dose-effect equations the two parameters of the logistic equation, β 1 (which determines the horizontal location of the dose-effect curve) and β 2 , (which determines the slope) were entered into a data base arranged according to the solvent and motivation rank (minimum, medium or high according to Table 1 ). These two curve-fitting parameters were then tested separately for significant differences using a two-way (solvent by motivation) analysis of variance (ANOVA) performed with PROC MIXED (SAS, Cary, NC). Because of few data entries per cell and some missing data, only main effects and only one parameter could be tested at a time. Because two correlated dependent variables (β 1 and β 2 ) were tested together, but with separate tests, the significance criterion was set at α / 2.0 or 0.025. If a significant main effect was found, pairwise stepdown tests were conducted with α = 0.05.
Dose-equivalence equations (DEEs) were also computed to estimate the solvent concentrations in human brains that were equivalent to concentrations in rat brains, for effects of equal magnitude . The curve defined by the DEE gives 
Thus the concentrations in human brain (D H ) may be expressed in terms of the concentrations in rat brain (D R ) that produced equal effects and the empirical parameters for the two logistic dose-effect equations. Table 1 defines the motivation ranks and relates them to the particular experiments and tasks that were used in the present work. Dependent variables in the various studies are also defined in Table 1 . The number of studies, the total number of subjects studied and the total number of observations (or means) for all studies are given in Table 2 . Publications providing these data are shown in the Appendix, Tables A1-A4 .
RESULTS
THE FITTED DOSE-EFFECT CURVES
All Solvents and Motivation Ranks. Figure 1 is a plot of all of the dose-effect curves fitted for each solvent and the motivation rank of the experiment in which the data were collected. The color-shaded areas are bounded on the left and right by the most leftward and the most rightward of the confidence limits from any of the included fitted curves, respectively. It appears that the human (blue) and rat VEP curves (red), and their confidence limits, overlap entirely but the human curves (for all their limited range of brain solvent concentrations) have shallower slopes and/or are shifted to the right of the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 rat VEP curves. The curves of more highly-motivated behaviors (green and black) are shifted to the right of the human and rat VEP curves, and their confidence limits do not overlap, except at very low doses where all curves necessarily converge at the origin. In addition, it appears that the curves cluster by motivation rank rather than by solvent because (a) the curves for each solvent lie within each other's confidence interval within each motivation rank and (b) their relative left/right positions are not similar across motivation ranks.
The effect of motivation rank was statistically significant for both β 1 (F = 28.14, d. f. = 3, 6 and p = 0.0006) and for β 2 (F = 19.94, d. f. = 3,6 and p = .0016). Thus, H 1 was sustained. The neurobehavioral effect of each solvent increased with increasing concentration and, for a given concentration, decreased as a function of the motivation strength in the testing situation. For example, the effect of 500 µM TOL was greater in the VEP test (where no motivation was applied) than in the moderately-motivated signaldetection task and was smallest in the highly-motivated ES-AV task (Figure 1 ). This latter finding was explored by paired stepdown tests. Table 3 gives the results of the 12 pairwise stepdown tests for β 1 and β 2 for each of the six possible pairs of motivation rank comparisons. For all but row 1 of Table 3 , tests for pairwise comparisons of β 1 were consistently significant indicating that β 1 differed for all of the dissimilar-motivation pairs. The same comparisons were also significant for β 2 , except for the REW (medium motivation) vs. ES-AV (high motivation) pair. Note that the first row of Table 3 provides a test of H 3 which was sustained. This supported the previous observation ) that rat and human dose-effect curves did not differ significantly in lowmotivation situations.
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Thus, H 2 was not sustained suggesting that the four solvents do not differ in potency for neurobehavioral effects as a function of molar concentration in brain.
Pooling the Data for the Four Solvents. Because the dose-effect curves for the four solvents were shown to not differ from each other at any given motivation level, dose-effect data from all solvents within each motivation rank were pooled and fit to a single dose-effect curve per motivation rank ( Figure 2 ). This pooling and fitting yielded increased parsimony and precision because of the greater number of observations per fitted curve. Despite their lack of significant differences, the human data and rat VEP data were kept separate to test their relationship with the greater precision afforded by pooling across solvents.
Clearly, the confidence interval around each fitted line in Figure 2 is substantially narrowed and the difference between motivation ranks is maintained and extended. The major difference is that the human RT and rat VEP curves became separated, suggesting that when estimates were made with smaller confidence intervals, human and rat doseeffect curves no longer overlie each other and the human curve lies to the right of the rat VEP curve. This pattern questions the validity of H 3 and suggests either that rats and humans are not equally sensitive to solvents under test conditions of minimum motivation, or that humans performed the RT tasks with some degree of motivation despite the lack of an explicit contingency for rapid responding, in contrast to the electrophysiological experiments with rats. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 5% and 10% effective doses (ED-5 and ED-10) were calculated and plotted in Figure 3 as log functions of motivation rank. Confidence limits were estimated using a Monte Carlo simulation (Benignus, 2001) . Figure 4a depicts the equivalence relationship between humans and rats in the lowest motivation rank. Here it can be seen that equivalent effect sizes are produced by solvent concentrations of, e.g., 30 µM in rats and ca. 270 µM in humans, with confidence limits (in humans) ranging from 178 to 445 µM. Because this particular DEE curve is nearly linear, (compared to the other two DEE curves) it is reasonable to state that the VEP response in rats appears to be ca. nine times more sensitive to acutelyinhaled solvents than is the RT behavioral measure in humans.
Quantitative Extrapolation via
The other two DEE plots (Figures 4b and 4c ) demonstrate nonlinear relationships between human and rat sensitivity to inhaled solvents and hence do not indicate a 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 constant ratio or difference of sensitivity between the two species. Instead, the ratio or difference of sensitivity depends on the brain solvent concentrations. Figures 4b and 4c also illustrate that when rats work under conditions of greater applied motivation, higher brain concentrations are required to produce the same effect magnitude as in humans.
The horizontal scales for Figures 4a through 4c are different, to better show the form of the relationship. Figure 4d shows the three DEEs on the same dose scale.
DISCUSSION
DOSE-EFFECT CURVES
Equipotency of the Four Solvents. Contrary to expectations, all of the solvents appear to have essentially the same potency when dose-effect relationships were expressed as a function of estimated molar concentration of the solvent in the brain.
Apparently, if differences among the delivered target tissue doses were accounted for by application of PBPK models, no further sensitivity differences among the four solvents remained. This finding was unexpected because in vitro tests showed that the molar potencies of TOL and PERC differ on nicotinic acetylcholine receptors (Bale et al., 2005) and TOL, TCE and PERC differ on voltage-gated calcium channels .
Another possibility, therefore, is that the current data set provided too little statistical power to detect the possible population differences in potency between the four solvents.
Motivation Rank. The potency of the four solvents is clearly determined more by the motivation ranks under which the subjects were tested than by the specific chemicals to which they were exposed. The stronger the applied motivation, the more resistant performance was to degradation by solvent exposure. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 H 3 , that humans and rats should have the same sensitivity to solvents because they were both tested in the minimum-motivation rank was not strongly supported in the separate-solvent analysis, and not supported at all in the pooled-solvent analysis (See Figures 1 and 2 ). If the two species are not equally sensitive in this minimum-motivation condition, then the generality of the motivation hypothesis may be called into question.
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However, it is possible that humans were, in fact motivated to comply with instructions to do well, even when no explicit consequences for good performance existed, whereas rats in the VEP test were not required to respond overtly and thus not affected by applied motivation. This possibility preserves and extends the motivation hypothesis to a fourth category of "no motivation" beyond the minimal-motivation category hypothesized for human testing. Another possibility is that humans are differently sensitive (or the tests used are differently sensitive) from other species or tests. The motivation hypotheses may simply be wrong, however it is phrased, but it does explain a large amount of variation in the present set of data and therefore, it would seem that differentiating "nomotivation" passive electrophysiological tests from "minimum-motivation" human testing is the most reasonable conclusion. These conclusions should be viewed with caution. Other dependent variables, experimental designs or toxicants might yield different conclusions.
Dose-Equivalence Equations. Despite large differences in sensitivity among tests
of the effects of acute inhaled solvents, the extent of human impairment may be estimated from rat behavior by employment of the appropriate DEE. Thus, if humans are engaged in a task with only minimum motivation, the behavioral effects of solvent exposure can be estimated from DEEs plotted in Figure 3a , 3b or 3c, depending on available rat data.
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Toxicological Sciences   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 EXTRAPOLATION Benignus et al. (2007) hypothesized that if humans were engaged in tasks under conditions involving rewards or escape of aversive events, then the effects of solvent exposure should be estimated from rat tasks under similar motivation by employing a 1:1 DEE. The validity of this hypothesis cannot be tested, however, unless human data become available for behavior in higher motivation conditions. The lack of human data collected under higher motivation levels requires that this hypothesis be classified as an empirically-based extrapolation In instances where some solvent (other than the four analyzed here) were to be tested only in rats, it may be appropriate to use the rat-only data directly in the DEE equations, as best estimates, to extrapolate the results to humans. An extrapolation may be more defensible if it uses DEEs directly only if the newly-tested solvent had a doseeffect curve similar to those observed in this report. Such a cross-species extrapolation would be quantitative, with confidence intervals, and would be appropriate to a wide range of effects. If it became desirable to reduce the information to some threshold-like measure for regulatory purposes, the estimates derived from human dose-effect curves based on pooled data would be defensible. For example, such a pooled dose-effect analysis formed the basis of recent assessments of styrene conducted by both state and federal agencies (ATSDR MRL, 2007; Texas ESL, 2008) .
Extrapolations from effects of single-solvent exposure to effects of multi-solvent exposure can be made quantitatively by simply adding the molar brain doses and proceeding to enter the combined molar dose into the dose-effect curve for the appropriate species and motivation. This procedure is justified because the sum of the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 concentrations of individual solvents in the brain would yield a higher equivalent concentration on the same dose-effect curve. This depends, of course, on accurate PBPK models for multiple solvent exposures accounting for potential metabolic interactions, and the generality of the finding that solvents are equipotent when their brain concentration is expressed in molar units.
Extrapolations from observed concentrations to the effects of greater (unobserved) concentrations can also be made using the dose-effect curves. Such extrapolations might be of use in cases of industrial accidents. Inferences about concentrations between the known zero effect and a lowest-observed effect can be made by interpolation using the dose-effect curve.
CRITIQUE
One of the difficulties with summarizing extant literature (whether by metaanalyses or simply a qualitative review and discussion) is that the data entering the summary do not originate from a controlled experiment, even though the original individual experiments may have, themselves, been well-controlled. Thus, there is always the possibility that conclusions derived from a meta-analysis are due to some sampling error or bias, such as the tendency to not publish negative results (Rosenthal, 1979) . It should be recognized that literature summaries are best considered as generating hypotheses for further testing. If, however, the analysis reveals systematic relationships that are supported by plausible explanations, then the analysis provides a better explanation than the un-summarized body of information and can guide both decisions about hazards and plans for further research.
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SUMMARY AND CONCLUSIONS 1. Contrary to expectation, the four tested solvents did not significantly differ in acuteexposure potency when functional effects were measured on a common scale and the dose variable was expressed as estimated molar concentration in brain.
2. The acute-exposure potency of each of the solvents was an inverse function of the strength of motivation involved in performing the task.
3. When effects were averaged across solvents, passive tests in rats (VEP) appeared to be more sensitive to disruption than active tests in humans or rats.
4. Quantitative dose-effect extrapolation with confidence intervals from rats to humans was possible by application dose-equivalence equations.
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